Symptom-cluster pattern most consistent with immune dysregulation, with secondary mold cirs pattern signals. Recovery stage: improving. This is a pattern for clinical review — not a diagnosis.
| Marker | Result | Band |
|---|---|---|
| eosinophils | 8 | high |
Anaphylaxis history is a critical reaction-risk consideration.
High-reactivity or severe flare history may increase risk of intolerance.
MCAS/high-reactivity history may increase risk of intolerance.
Clinical decision-support only — not a diagnosis. Axiom recognizes symptom-cluster patterns and organizes evidence. Scores are heuristic and attributable. They do not diagnose, interpret labs in isolation, or recommend or dose treatment. All clinical decisions rest with the reviewing physician.